Onconetix, Inc. Files 8-K on Material Agreement

Ticker: ONCO · Form: 8-K · Filed: 2025-06-11T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, financial-obligation, corporate-update

TL;DR

Onconetix just filed an 8-K for a material agreement and financial obligation. Big moves ahead.

AI Summary

Onconetix, Inc. filed an 8-K on June 11, 2025, reporting a material definitive agreement and a direct financial obligation. The company, formerly known as Blue Water Biotech, Inc. and Blue Water Vaccines Inc., is incorporated in Delaware and headquartered in Cincinnati, Ohio.

Why It Matters

This filing indicates significant new contractual commitments or financial obligations for Onconetix, Inc., which could impact its financial health and strategic direction.

Risk Assessment

Risk Level: medium — The filing indicates new financial obligations and material agreements, which carry inherent risks related to execution and financial impact.

Key Players & Entities

Onconetix, Inc. (company) — Registrant
Blue Water Biotech, Inc. (company) — Former company name
Blue Water Vaccines Inc. (company) — Former company name
June 11, 2025 (date) — Date of report

FAQ

What is the nature of the material definitive agreement Onconetix, Inc. entered into?

The filing does not specify the details of the material definitive agreement, only that one was entered into.

What is the direct financial obligation being reported by Onconetix, Inc.?

The filing indicates the creation of a direct financial obligation but does not provide specific details about its nature or amount.

When was the report filed and what is the earliest event date?

The report was filed on June 11, 2025, and the earliest event reported is also June 11, 2025.

What were Onconetix, Inc.'s previous company names?

Onconetix, Inc. was formerly known as Blue Water Biotech, Inc. (name change on April 24, 2023) and Blue Water Vaccines Inc. (name change on July 10, 2019).

Where is Onconetix, Inc. headquartered?

Onconetix, Inc. is headquartered in Cincinnati, Ohio, with its business address at 201 E. Fifth Street, Suite 1900.

From the Filing

0001213900-25-053367.txt : 20250611 0001213900-25-053367.hdr.sgml : 20250611 20250611130022 ACCESSION NUMBER: 0001213900-25-053367 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250611 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Material Modifications to Rights of Security Holders ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250611 DATE AS OF CHANGE: 20250611 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Onconetix, Inc. CENTRAL INDEX KEY: 0001782107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41294 FILM NUMBER: 251039488 BUSINESS ADDRESS: STREET 1: 201 E. FIFTH STREET STREET 2: SUITE 1900 CITY: CINCINNATI STATE: OH ZIP: 45202 BUSINESS PHONE: 513-620-4101 MAIL ADDRESS: STREET 1: 201 E. FIFTH STREET STREET 2: SUITE 1900 CITY: CINCINNATI STATE: OH ZIP: 45202 FORMER COMPANY: FORMER CONFORMED NAME: Blue Water Biotech, Inc. DATE OF NAME CHANGE: 20230424 FORMER COMPANY: FORMER CONFORMED NAME: Blue Water Vaccines Inc. DATE OF NAME CHANGE: 20190710 8-K 1 ea0245387-8k_onconetix.htm CURRENT REPORT false --12-31 0001782107 0001782107 2025-06-11 2025-06-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of report (Date of earliest event reported): June 11, 2025   Onconetix, Inc. (Exact name of registrant as specified in its charter)   Delaware   001-41294   83-2262816 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   201 E. Fifth Street , Suite 1900 Cincinnati , Ohio   45202 (Address of principal executive offices)   (Zip Code)   Registrant’s telephone number, including area code: ( 513 ) 620-4101   Not Applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.00001 per share   ONCO   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐           Item 1.01. Entry Into a Material Definitive Ag